长非编码RNA UCA1在肿瘤中的表达及作用

国际肿瘤学杂志››2015,Vol. 42››Issue (7): 519-521.doi:10.3760/cma.j.issn.1673-422X.2015.07.011

长非编码RNA UCA1在肿瘤中的表达及作用

赵义，张行行，徐岷

212000 镇江，江苏大学附属医院消化内科

出版日期:2015-07-08发布日期:2015-05-26
通讯作者:徐岷 E-mail:peterxu1974@163.com
基金资助:

江苏省卫生厅医学科研课题（H201434）；镇江市社会发展科技支撑计划（SH2014024）

Expressions and roles of long non-coding RNA UCA1 in tumors

Zhao Yi, Zhang Xingxing, Xu Min

Department of Gastroenterology, Affiliated Hospital of Jiangsu University, Zhenjiang 212000, China

Online:2015-07-08Published:2015-05-26
Contact:Xu Min E-mail:peterxu1974@163.com

摘要/Abstract

摘要：尿路上皮癌相关抗原1（UCA1）是一种膀胱癌特异性长非编码RNA，无编码蛋白质的功能。UCA1差异性表达于各种胎儿组织，而大多数成人组织不表达UCA1，在肿瘤形成过程中UCA1再次表达。研究表明UCA1可调控膀胱癌、乳腺癌和肝癌等肿瘤的增殖、凋亡、转移和耐药性。

赵义，张行行，徐岷. 长非编码RNA UCA1在肿瘤中的表达及作用[J]. 国际肿瘤学杂志, 2015, 42(7): 519-521.

Zhao Yi, Zhang Xingxing, Xu Min. Expressions and roles of long non-coding RNA UCA1 in tumors[J]. Journal of International Oncology, 2015, 42(7): 519-521.

［1］ Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future［J］. Genetics, 2013, 193(3): 651-669. ［2］ Ghosal S, Das S, Chakrabarti J. Long noncoding RNAs: new players in the molecular mechanism for maintenance and differentiation of pluripotent stem cells［J］. Stem Cells Dev, 2013, 22(16): 2240-2253. ［3］ Huarte M, Rinn JL. Large noncoding RNAs: missing links in cancer?［J］. Hum Mol Genet, 2010, 19(R2): R152-161. ［4］ Wang XS, Zhang Z, Wang HC, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma［J］. Clin Cancer Res, 2006, 12(16): 4851-4858. ［5］ Xie XJ, Li X, Wang F, et al. Cellular localization and tissue expression pattern of UCA1, a noncoding RNA［J］. Nan Fang Yi Ke Da Xue Xue Bao, 2010, 30(1): 57-60. ［6］ Wu W, Zhang S, Li X, et al. Ets2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long noncoding RNA, in bladder cancer cells［J］. PLoS One, 2013, 8(9): e73920. ［7］ Xue M, Li X, Wu W, et al. Upregulation of long noncoding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis［J］. Oncol Rep, 2014, 31(5): 1993-2000. ［8］ Wang T, Yuan J, Feng N, et al. HsamiR1 downregulates long noncoding RNA urothelial cancer associated 1 in bladder cancer［J］. Tumour Biol, 2014, 35(10): 10075-10084. ［9］ Wang X, Gong Y, Jin B, et al. Long noncoding RNA urothelial carcinoma associated 1 induces cell replication by inhibiting BRG1 in 5637 cells［J］. Oncol Rep, 2014, 32(3): 1281-1290. ［10］ Yang C, Li X, Wang Y, et al. Long noncoding RNA UCA1 regulated cell cycle distribution via CREB through PI3K dependent pathway in bladder carcinoma cells［J］. Gene, 2012, 496(1): 8-16. ［11］ Huang J, Zhou N, Watabe K, et al. Long noncoding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1)［J］. Cell Death Dis, 2014, 5: e1008. ［12］ Hiemer SE, Szymaniak AD, Varelas X. The transcriptional regulators TAZ and YAP direct transforming growth factor βinduced tumorigenic phenotypes in breast cancer cells［J］. J Biol Chem, 2014, 289(19): 13461-13474. ［13］ Jiang M, Huang O, Xie Z, et al. A novel long noncoding RNAARA: adriamycin resistanceassociated［J］. Biochem Pharmacol, 2014, 87(2): 254-283. ［14］ Li JY, Ma X, Zhang CB. Overexpression of long noncoding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma［J］. Int J Clin Exp Pathol, 2014, 7(11): 7938-7944. ［15］ Wang F, Ying HQ, He BS, et al. Upregulated lncRNAUCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR216b and activation of FGFR1/ERK signaling pathway［J］. Oncotarget, 2015, In press. ［16］ Han Y, Yang YN, Yuan HH, et al. UCA1, a long noncoding RNA upregulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution［J］. Pathology, 2014, 46(5): 396-401. ［17］ Kaneko K, Ito Y, Ono Y, et al. Gene expression profiling reveals upregulated UCA1 and BMF in gallbladder epithelia of children with pancreaticobiliary maljunction［J］. J Pediatr Gastroenterol Nutr, 2011, 52(6): 744-750. ［18］ Yang X, Gao L, Guo X, et al. A network based method for analysis of lncRNAdisease associations and prediction of lncRNAs implicated in diseases［J］. PLoS One, 2014, 9(1): e87797. ［19］ Tian Y, Zhang X, Hao Y, et al. Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat1 in metastasis of melanoma［J］. Melanoma Res, 2014, 24(4): 335-341. ［20］ Liu SP, Yang JX, Cao DY, et al. Identification of differentially expressed long noncoding RNAs in human ovarian cancer cells with different metastatic potentials［J］. Cancer Biol Med, 2013, 10(3): 138-141. ［21］ Fang Z, Wu L, Wang L, et al. Increased expression of the long noncoding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis［J］. Oral Surg Oral Med Oral Pathol Oral Radiol, 2014, 117(1): 89-95.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺.PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.